PCMA Statement on CMS’ Proposed Part D Changes

Share Article

“CMS was wise to reconsider its proposed Part D rule that would have destabilized the program, increased costs, and disrupted coverage for millions of seniors.”

Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt issued the following statement on today’s letter from Centers for Medicare & Medicaid Services (CMS) Administrator Marilyn Tavenner to Congress on the proposed Part D rule:

“CMS was wise to reconsider its proposed Part D rule that would have destabilized the program, increased costs, and disrupted coverage for millions of seniors. While we welcome this temporary reprieve, we still await the final rule. However, today’s announcement appears to be a step in the right direction for Medicare Part D beneficiaries.”

Share article on socal media or email:

View article via:

Pdf Print